Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis (PsA)

Clinical trial NCT01307423 · COMPLETED

Trial details

NCT number: NCT01307423
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Psoriatic Arthritis

Start date: 2010-12-09
Primary completion: 2013-02-21
Enrollment: 529

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.